NCT00110851 Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet) Status COMPLETED Phase PHASE2
NCT00110435 A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077) Status COMPLETED Phase PHASE3
NCT00108004 Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT00106808 Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00103935 Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00103857 MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036) Status COMPLETED Phase PHASE3
NCT00099619 Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy Status COMPLETED Phase PHASE3
NCT00099333 Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents Status COMPLETED Phase PHASE2
NCT00099320 Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin Status COMPLETED Phase PHASE3
NCT00097500 Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00036504 Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin Status COMPLETED Phase PHASE4
NCT00032487 Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT) Status COMPLETED Phase PHASE3
NCT00032474 Ginkgo Biloba Extract and the Insulin Resistance Syndrome Status COMPLETED Phase PHASE1/PHASE2